Arthur Kirsch
Directeur/Membre du Conseil chez LIQUIDIA CORPORATION
Fortune : 395 840 $ au 30/04/2024
Provenance du réseau au premier degré de Arthur Kirsch
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Drexel Burnham Lambert, Inc.
192
| Extinct | Agricultural Commodities/Milling | 192 |
31
| Subsidiary | Pharmaceuticals: Major | 31 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Public Company | Pharmaceuticals: Major | 21 | |
| Private Company | Pharmaceuticals: Major | 19 | |
Anavasi Diagnostics
9
| Private Company | 9 | |
| Subsidiary | Biotechnology | 7 | |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999.
6
| Subsidiary | Investment Banks/Brokers | 6 |
Natwest Securities Corp.
4
| Extinct | 4 | |
| Subsidiary | Biotechnology | 3 | |
Prudential Vector Healthcare Group
2
| Extinct | Investment Managers | 2 |
NatWest Securities Ltd.
1
| Extinct | Investment Banks/Brokers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Arthur Kirsch via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Founder | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Human Resources Officer Chief Executive Officer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Investment Managers | Private Equity Investor Private Equity Investor | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Director/Board Member Masters Business Admin Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Graduate Degree Undergraduate Degree Masters Business Admin | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Director of Finance/CFO | |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer General Counsel Chief Executive Officer | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Secretary | |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer Director/Board Member | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
| Kellogg School of Management | College/University | Graduate Degree Masters Business Admin | |
| G.C. Andersen Partners LLC | Private Equity Investor Private Equity Investor | ||
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| New York University | College/University | Doctorate Degree Graduate Degree | |
| Washington & Lee University | College/University | Undergraduate Degree Undergraduate Degree | |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| The Pennsylvania State University | College/University | Doctorate Degree Undergraduate Degree | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| Simmons University | College/University | Graduate Degree Undergraduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Masters Business Admin | |
| Rutgers University- Newark | College/University | Undergraduate Degree Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 48 |
| Royaume-Uni | 3 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 17 |
| Finance | 10 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 530 |
| Corporate Officer/Principal | 276 |
| Independent Dir/Board Member | 138 |
| Chairman | 88 |
| Undergraduate Degree | 81 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jonathan Sokoloff | 72 |
| Ed Mathers Mathers | 47 |
| Leon Black | 41 |
| Ralph Snyderman | 41 |
| Kenneth Lee | 40 |
| Paul Levy | 39 |
| Seth A. Rudnick | 36 |
| Richard Williams | 35 |
| Michael Gross | 34 |
| Alf Gunnar Martin Nicklasson | 31 |
| Paul Manning | 26 |
| Stelios Papadopoulos | 26 |
| Isaac Cheng | 25 |
| Stephen Bloch | 23 |
| A. Levison | 22 |
- Bourse
- Insiders
- Arthur Kirsch
- Connexions Sociétés
